RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons

Overview of attention for article published in JAMA: Journal of the American Medical Association, October 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 113 news outlets
blogs: 6 blogs
twitter: 71 X users
facebook: 2 Facebook pages

video: 1 YouTube creator
guideline: 1 clinical guideline source
bluesky: 22 Bluesky users
podcasts: 1 podcast

Readers on

mendeley: 45 Mendeley

So far, Altmetric has seen 26 Bluesky posts from 22 Bluesky users, with an upper bound of 67,432 followers.

Vacunas contra el virus sincitial respiratorio previene la hospitalización asociada con el virus durante 2 temporadas en adultos mayores, con una efectividad menor en los pacientes inmunocomprometidos o con enfermedad CV #RSV #vaccine #older jamanetwork.c…

RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons jamanetwork.com/journals/jam...

jamanetwork.com/journals/jam...

RP @jama.com: In adults aged 60 years or older, RSV vaccines reduced RSV-associated hospitalizations over 2 seasons, although effectiveness waned among immunocompromised patients and those with cardiovascular disease. ja.ma/47dV57B

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity, including 22 additional Bluesky posts.